Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CASI Pharmaceuticals (CASI) Equity Ratio (2021 - 2024)

Historic Equity Ratio for Pharmaceuticals (CASI) over the last 4 years, with Q4 2024 value amounting to 0.03.

  • Pharmaceuticals' Equity Ratio fell 8925.85% to 0.03 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.03, marking a year-over-year decrease of 8925.85%. This contributed to the annual value of 0.03 for FY2024, which is 8925.85% down from last year.
  • As of Q4 2024, Pharmaceuticals' Equity Ratio stood at 0.03, which was down 8925.85% from 0.32 recorded in Q4 2023.
  • Over the past 5 years, Pharmaceuticals' Equity Ratio peaked at 413822.33 during Q2 2023, and registered a low of 0.03 during Q4 2024.
  • For the 4-year period, Pharmaceuticals' Equity Ratio averaged around 82764.75, with its median value being 0.46 (2022).
  • Its Equity Ratio has fluctuated over the past 5 years, first crashed by 2419.43% in 2022, then crashed by 8925.85% in 2024.
  • Quarter analysis of 4 years shows Pharmaceuticals' Equity Ratio stood at 0.61 in 2021, then decreased by 24.19% to 0.46 in 2022, then tumbled by 30.69% to 0.32 in 2023, then plummeted by 89.26% to 0.03 in 2024.
  • Its Equity Ratio was 0.03 in Q4 2024, compared to 0.32 in Q4 2023 and 413822.33 in Q2 2023.